Shiv Ram Krishn - Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center

基本信息

Career Trajectory

Bio

I am a biomedical professional with an enduring passion and goal to advance human healthcare through innovative research and technology. With more than ten years of working experience in clinical and biomedical research setups, I have leveraged my expertise in biochemistry, cell and molecular biology to discover novel biomarkers and therapeutic targets for multiple cancer types. I thrive on having detail-oriented, analytical mindset complemented with strong communication and organizational skills with experience of cross-functional teaming and delivering results in narrow time frames.

Research Interests

Papers共 43 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Fig. 1 from MUC4-Mediated Regulation of Acute Phase Protein Lipocalin 2 Through HER2/AKT/NF-κB Signaling in Pancreatic Cancer

Sukhwinder Kaur,Neil Sharma,Shiv Ram Krishn,Imay Lakshmanan, Satyanarayana Rachagani,Michael J. Baine,Lynette M. Smith,Subodh M. Lele,Aaron R. Sasson, Sushovan Guha,Kavita Mallya,Judy M. Anderson,Michael A. Hollingsworth,Surinder K. Batra

openalex（2023）

Cited0Views0Bibtex

Supplementary Data from BCA101 is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth

Srinivas Reddy Boreddy,Reshmi Nair,Prashant Kumar Pandey,Anshu Kuriakose,Arindam Banerjee,Chaitali Dey, A. R. Madhukara,Bhadravathi Marigowda Shivakumar,Hanumant Kulkarni,Milind Sagar,M. V. Prashantha Kumar,Shiv Ram Krishn,Jaya Bhatnagar, Moni Abhram Kuriakose,Ram Bhupal Reddy,Amritha Suresh,Praveen Reddy Moole,Usha Bughani,Seng-Lai Tan,Pradip Nair,Rachel Salazar

Cancer Researchno. 11 (2023): 1883-1904

Cited7Views0WOSBibtex

Preliminary Immune Correlatives from BCA101 Trial Show Favorable Modulation of Tumor Immune Microenvironment

Patrick H. Lizotte,Paul Paik,Liviu Niculescu,Seng-Lai H. Tan,David Bohr,Elham Gharakhani,Ralf Reiners,Rachel Salazar, Avanish Varshney,Shiv Ram Krishn,Pradip Nair,Cloud Paweletz

Cancer Researchno. 7_Supplement (2023): 6677-6677

Cited0Views0Bibtex

Supplementary Fig. 3 from MUC4-Mediated Regulation of Acute Phase Protein Lipocalin 2 Through HER2/AKT/NF-κB Signaling in Pancreatic Cancer

openalex（2023）

Cited0Views0Bibtex

Supplementary Fig. 2 from MUC4-Mediated Regulation of Acute Phase Protein Lipocalin 2 Through HER2/AKT/NF-κB Signaling in Pancreatic Cancer

openalex（2023）

Cited0Views0Bibtex

Supplementary Information from MUC4-Mediated Regulation of Acute Phase Protein Lipocalin 2 Through HER2/AKT/NF-κB Signaling in Pancreatic Cancer

openalex（2023）

Cited0Views0Bibtex

1426 Combination with BCA101 Improves the Efficacy of KRAS-G12C Inhibitor and Overcomes G12C Inhibitor-Induced Resistance in Lung and Colon Cancer Cell Lines

Rachel Salazar,Reshmi Nair,Pradip Nair,Veena Somasundaram,Shiv Ram Krishn

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

Cited0Views0Bibtex

A novel bispecific bca356 targeting tumour antigen caix conjugated to an attenuated il12 demonstrates pre-clinical efficacy with potential for limited systemic toxicity

Pradip Nair,Arvind Goswamy,Jaya Bhatnagar,Srinivas Boreddy,Reshmi Nair,Shiv Krishn,Anshu Kuriakose,Prashanth Pandey,Hanumant Kulkarni,Kishore Punnath,Milind Sagar,V Prashanthakumara,T. K. Thulsi,Abhishek Sinha,D. R. Ravindra,Rachel Salazar

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022): A1419-A1420

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn